Volume 6, Issue 1, February 2018, Pages: 24-28
Received: Dec. 11, 2017;
Accepted: Jan. 30, 2018;
Published: Feb. 27, 2018
Views 2156 Downloads 132
Almojtaba AbdAlkhalig Ahmed Bakheet, Department of Family Sciences (Nutrition and Dietetics), Faculty of Education, University of Khartoum, Khartoum, Sudan
This review gives a survey on the representative role concerning the nutritional care of valve heart disease patients under warfarin drug treatment, the objectives of this work is to give a nutritional views to the valve heart disease from the disease definition, determining Risks, Complications, surgical outcome and risk of procedure, It also highlights the blood coagulation, warfarin drug and its effects and the role of nutritional support in the treatment of valve heart disease patients.
Almojtaba AbdAlkhalig Ahmed Bakheet,
Nutritional Care for Valve Heart Disease Patients Under Warfarin Drug Treatment, Science Research.
Vol. 6, No. 1,
2018, pp. 24-28.
Copyright © 2018 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/
) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
American Heart Association, Inc -- 10000056 Heart and Stroke Encyclopedia. American Heart Association, Inc. Retrieved 2010-08-05.
Jr S S, Allen J, Blair S N, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute.[J]. Journal of the American College of Cardiology, 2006, 47(10): 2130-9.
Vukasinović M, Djukić V, Stanković P, et al. International Statistical Classification of Diseases and Related Health Problems [J]. Acta Chirurgica Iugoslavica, 2009, 56 (3): 65-9.
Andersohn F, Suissa S, Garbe E. Cyclooxygenase inhibitors and cardiovascular risk [J]. Jama the Journal of the American Medical Association, 2007, 297 (6): 587-8.
Torracca L, Schreuder J J, Quarti A, et al. Acute effects of beating heart coronary surgery on left ventricular performance. [J]. Annals of Thoracic Surgery, 2002, 74(4): 1348-1352.
Wajima T, Isbister G K, Duffull S B. A comprehensive model for the humoral coagulation network in humans. [J]. Clinical Pharmacology & Therapeutics, 2009, 86 (3): 290–298.
Guyton, Arthur C. Guyton and Hall textbook of medical physiology/[M]. Saunders/Elsevier, 2011.
Harris J. Interaction of dietary factors with oral anticoagulants: review and applications. J Am Diet Assoc. 1995; 95: 580-584.
Calonge N, Petitti D B, Dewitt T G, et al. Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement.[J]. Annals of Internal Medicine, 2009, 150 (6): 396.
Hirsh J, Fuster V, Ansell J, et al. American Heart Association/American College of Cardiology Foundation guide to warfarin therapy. [J]. Journal of the American College of Cardiology, 2003, 107(12): 1692.
Goldhaber S Z. Optimal duration of anticoagulation after venous thromboembolism: fixed and evidence-based, or flexible and personalized? [J]. Annals of Internal Medicine, 2009, 150(9): 644-646.
Yamreudeewong W, Henann N, Fazio A, Lower D, Cassidy T. Drug-food interactions in clinical practice. J Fam Pract. 1995; 40(4): 376-384.
Brigden M. Oral anticoagulant therapy. Postgrad Med 1996; 99(6): 81-100.
Girolami A, Scandellari R, Zanon E, et al. Non-catheter associated venous thrombosis in hemophilia A and B. A critical review of all reported cases. [J]. Journal of Thrombosis & Thrombolysis, 2006, 21(3): 279-84.
Couris R, Tataronis G, Mccloskey W, et al. Dietary vitamin K variability affects International Normalized Ratio (INR) coagulation indices[J]. International journal for vitamin and nutrition research. Internationale Zeitschriftfür Vitamin- und Ernährungsforschung. Journal international de vitaminologieet de nutrition, 2006, 76(2): 65.
Izzo A A, Carlo G D, Borrelli F, et al. Cardiovascular pharmacotherapy and herbal medicines: the risk of drug interaction[J]. International Journal of Cardiology, 2005, 98(1): 1.